These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38074724)

  • 21. Antimicrobial resistance patterns and serotype distribution of invasive Streptococcus pneumoniae isolates from children in Taiwan from 1999 to 2004.
    Lin WJ; Lo WT; Chou CY; Chen YY; Tsai SY; Chu ML; Wang CC
    Diagn Microbiol Infect Dis; 2006 Oct; 56(2):189-96. PubMed ID: 16725302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiological and molecular characterization of Streptococcus pneumoniae carriage strains in pre-school children in Arkhangelsk, northern European Russia, prior to the introduction of conjugate pneumococcal vaccines.
    Vorobieva S Jensen V; Furberg AS; Slotved HC; Bazhukova T; Haldorsen B; Caugant DA; Sundsfjord A; Valentiner-Branth P; Simonsen GS
    BMC Infect Dis; 2020 Apr; 20(1):279. PubMed ID: 32293324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial resistance among isolates causing invasive pneumococcal disease before and after licensure of heptavalent conjugate pneumococcal vaccine.
    Karnezis TT; Smith A; Whittier S; Haddad J; Saiman L
    PLoS One; 2009 Jun; 4(6):e5965. PubMed ID: 19536335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007.
    Hsu KK; Shea KM; Stevenson AE; Pelton SI;
    Pediatr Infect Dis J; 2010 Apr; 29(4):289-93. PubMed ID: 19935447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotype distribution and antimicrobial resistance of
    Sia SB; Lagrada ML; Gayeta JM; Masim MAL; Abad JP; Magbanua MA; Ablola FB
    Western Pac Surveill Response J; 2021; 12(4):1-8. PubMed ID: 35251742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine.
    Pelton SI; Huot H; Finkelstein JA; Bishop CJ; Hsu KK; Kellenberg J; Huang SS; Goldstein R; Hanage WP
    Pediatr Infect Dis J; 2007 Jun; 26(6):468-72. PubMed ID: 17529860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E; Albert MJ
    Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.
    Messina AF; Katz-Gaynor K; Barton T; Ahmad N; Ghaffar F; Rasko D; McCracken GH
    Pediatr Infect Dis J; 2007 Jun; 26(6):461-7. PubMed ID: 17529859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CIRCULATING CLONAL COMPLEXES AND SEQUENCE TYPES OF STREPTOCOCCUS PNEUMONIAE SEROTYPE 19A WORLDWIDE: THE IMPORTANCE OF MULTIDRUG RESISTANCE: A SYSTEMATIC LITERATURE REVIEW.
    Ruiz García Y; Nieto Guevara J; Izurieta P; Vojtek I; Ortega-Barría E; Guzman-Holst A
    Expert Rev Vaccines; 2021 Jan; 20(1):45-57. PubMed ID: 33507135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)].
    Artiles F; Horcajada I; Cañas AM; Alamo I; Bordes A; González A; Santana M; Lafarga B
    Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):14-21. PubMed ID: 19217998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial resistance in paediatric
    Andrejko K; Ratnasiri B; Hausdorff WP; Laxminarayan R; Lewnard JA
    Lancet Microbe; 2021 Sep; 2(9):e450-e460. PubMed ID: 34485957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotype changes and antimicrobial nonsusceptibility rates of invasive and non-invasive Streptococcus pneumoniae isolates after implementation of 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Bulgaria.
    Setchanova L; Murdjeva M; Stancheva I; Alexandrova A; Sredkova M; Stoeva T; Yoneva M; Kurchatova A; Mitov I
    Braz J Infect Dis; 2017; 21(4):433-440. PubMed ID: 28472614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in the antimicrobial susceptibilities and serotypes of Streptococcus pneumoniae: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2006-2010.
    Tsai HY; Chen YH; Liao CH; Lu PL; Huang CH; Lu CT; Chuang YC; Tsao SM; Chen YS; Liu YC; Chen WY; Jang TN; Lin HC; Chen CM; Shi ZY; Pan SC; Yang JL; Kung HC; Liu CE; Cheng YJ; Liu JW; Sun W; Wang LS; Ko WC; Yu KW; Chiang PC; Lee MH; Lee CM; Hsu GJ; Hsueh PR
    Int J Antimicrob Agents; 2013 Oct; 42(4):312-6. PubMed ID: 23849332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotypes and antibiotic resistance of non-invasive Streptococcus pneumoniae circulating in pediatric hospitals in Moscow, Russia.
    Mayanskiy N; Alyabieva N; Ponomarenko O; Lazareva A; Katosova L; Ivanenko A; Kulichenko T; Namazova-Baranova L; Baranov A
    Int J Infect Dis; 2014 Mar; 20():58-62. PubMed ID: 24462930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergence of antimicrobial-resistant serotype 19A Streptococcus pneumoniae--Massachusetts, 2001-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Oct; 56(41):1077-80. PubMed ID: 17947966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States.
    Farrell DJ; Klugman KP; Pichichero M
    Pediatr Infect Dis J; 2007 Feb; 26(2):123-8. PubMed ID: 17259873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PCV-15 and PPSV-23 coverage of invasive and respiratory tract Streptococcus pneumoniae, including MDR and XDR isolates: CANWARD 2007-20.
    Golden AR; Baxter M; Adam HJ; Martin I; Demczuk W; Mulvey MR; Karlowsky JA; Zhanel GG
    J Antimicrob Chemother; 2022 Apr; 77(5):1444-1451. PubMed ID: 35141750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014.
    Nakano S; Fujisawa T; Ito Y; Chang B; Suga S; Noguchi T; Yamamoto M; Matsumura Y; Nagao M; Takakura S; Ohnishi M; Ihara T; Ichiyama S
    Vaccine; 2016 Jan; 34(1):67-76. PubMed ID: 26602268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial susceptibility and serotype replacement of Streptococcus pneumoniae in children before and after PCV13 introduction in Taiwan.
    Huang H; Lin CY; Chiu NC; Huang DT; Huang CY; Chi H
    J Microbiol Immunol Infect; 2023 Apr; 56(2):299-310. PubMed ID: 36127232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) study.
    Kim SH; Song JH; Chung DR; Thamlikitkul V; Yang Y; Wang H; Lu M; So TM; Hsueh PR; Yasin RM; Carlos CC; Pham HV; Lalitha MK; Shimono N; Perera J; Shibl AM; Baek JY; Kang CI; Ko KS; Peck KR;
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1418-26. PubMed ID: 22232285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.